Shares of Datametrex AI Limited (CVE:DM - Get Free Report) dropped 8.7% on Wednesday . The company traded as low as C$0.11 and last traded at C$0.11. Approximately 4,857 shares were traded during trading, a decline of 89% from the average daily volume of 43,470 shares. The stock had previously closed at C$0.12.
Datametrex AI Price Performance
The stock has a 50 day moving average of C$0.08 and a 200-day moving average of C$0.04. The company has a current ratio of 0.40, a quick ratio of 2.44 and a debt-to-equity ratio of 554.49. The stock has a market capitalization of C$60.40 million, a P/E ratio of -1.43 and a beta of 2.59.
Datametrex AI Company Profile
(
Get Free Report)
Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.
Further Reading
Before you consider Datametrex AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Datametrex AI wasn't on the list.
While Datametrex AI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
